Variola Virus
Variola virus (or variola major) is the virus that causes smallpox. The virus is one of the members of the poxvirus group (Poxviridae) and it is one of the most complicated animal viruses. The variola virus is extremely virulent and is among the most dangerous of all the potential biological weapons.
The variola virus particle is shaped like a biconcave (concave on both sides) brick about 200 to 400 nm (nanometers) long. Its inner compartment contains a highly compressed double strand of deoxyribonucleic acid as well as about 100 proteins and 10 viral enzymes. The enzymes are used in nucleic acid replication.
The variola virus attaches to membrane receptors on the exterior of the host cell. The exact mechanisms involved in the binding to and penetration of the host membrane are not known. As it enters the cell, however, the virus loses its exterior membrane coat. Once inside the cell, the interior membrane layer is removed and the virus's proteins, enzymes, and DNA are released into the cytoplasm of the host cell where viral replication and assembly takes place. The production of variola virus by the host cell usually results in host cell death.
Variola virus infects only humans and can be easily transmitted from person to person via the air. Inhalation of only a few virus particles is sufficient to establish an infection. Transmission of the virus is also possible if items such as contaminated linen are handled. The common symptoms of smallpox include chills, high fever, extreme tiredness, headache, backache, vomiting, sore throat with a cough, and sores on mucus membranes and on the skin. As the sores burst and release pus, the afflicted person can experience great pain. Males and females of all ages are equally susceptible to infection. Prior to smallpox eradication approximately one third of patients died—usually within a period of two to three weeks following appearance of symptoms.
The origin of the variola virus in not clear. However, the similarity of the virus and cowpox virus
has prompted the suggestion that the variola virus is a mutated version of the cowpox virus. The mutation likely allowed the virus to infect humans. If such a mutation did occur, then it is possible that when early humans became more agricultural and less nomadic, there may have been selective pressure for the cowpox virus to adapt the capability to infect humans.
Vaccination to prevent infection by the variola virus was established in the 1700s. English socialite and public health advocate Lady Mary Wortley Montagu popularized the practice of injection with the pus obtained from smallpox sores as a protection against the disease. This technique became known as variolation. Late in the same century, Edward Jenner successfully prevented the occurrence of smallpox by an injection of pus from cowpox sores. This was the first vaccination. Vaccination against smallpox has been very successful; the variola virus is the only pathogenic virus that has been eliminated from the natural environment. Routine vaccination against smallpox was discontinued in the 1970s and considered globally eradicated in 1980. The last recorded case of naturally occurring smallpox infection was in 1977 in Somalia, Africa.
